by Bernard Marini, Anthony Perissinotti, et al.
Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
Language
🇺🇲
Publishing Since
3/11/2022
Email Addresses
1 available
Phone Numbers
0 available
April 7, 2025
<p>In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal management of CRS in patients receiving bispecific antibodies!</p><p><br></p><p>Inspired by this recent paper:</p><p>https://www.nature.com/articles/s41408-025-01222-y</p>
March 11, 2025
<p>In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be using this agent in AML? Tune in to find out!</p>
January 21, 2025
<p>In this episode, Anthony and Bernie are joined by two special guests to discuss recent updates to the use of blinatumomab in both adult and pediatric acute lymphoblastic leukemia (ALL), including the results of the AALL1731 trial and the full publication of ECOG1910. </p> <p>Julia Brown, PharmD, a Pediatric Hematology/Oncology Clinical Pharmacist and Lydia Benitez, an Adult Outpatient Leukemia Clinical Pharmacist bring their unique perspectives and expertise on the proper incorporation of blinatumomab into ALL care, as well as some of the major practical nuances that will be helpful to providers across the globe! </p> <p>Finally, for all of the Oncology Pharmacists in the audience, don't forget to fill out the <a href="https://www.surveymonkey.com/r/MXNVRBR" target="_blank" rel="noopener noreferer">HOPA Practice Outcomes and Professional Benchmarking Committee Survey! </a> </p>
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Sam and Karine
Vinay Prasad, MD MPH
Chadi Nabhan, MD, MBA, FACP
John Bossaer
American Society of Hematology
ASTCT
Dr. Neil Love
VJHemOnc
The Curious Clinicians
The Hematologist
NPR
The Leukemia & Lymphoma Society
Chadi Nabhan
Oncology Brothers
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.